Rahimi Mansour Farima, Keyvanfar Amirreza, Najafiarab Hanieh, Hooshmand Chayijan Shaghayegh, Farzaneh Farah, Mortezaei Golnoush
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Int J Fertil Steril. 2024 Jun 9;18(3):201-206. doi: 10.22074/ijfs.2024.2016339.1579.
Following COVID-19 vaccination, some women suffered from menstrual cycle disturbances. This study aimed to investigate menstrual cycle disturbances after COVID-19 vaccination in women of reproductive age.
This cross-sectional study was performed on 407 vaccinated women in the vaccination center of Imam Hossein Hospital (Tehran, Iran) between October 2021 and October 2022. They were interviewed based on a research-made checklist which consisted of two areas of questions about the baseline characteristics of participants and menstrual cycle characteristics to explore menstrual characteristics following COVID-19 vaccination.
The prevalence of menstrual disturbances was higher after the third dose (38.3%) compared with the second (27.9%) and first (17.7%) doses (P<0.001). After the first dose, a history of polycystic ovarian syndrome [PCOS, odds ratio (OR)=7.35, 95% confidential interval (CI)= (3.64-14.82), P<0.001] and menstrual disturbances with unknown etiology [OR=15.23, 95% CI=(6.30-36.80), P<0.001] could predict menstrual disturbances. After the second dose, a history of menstrual disturbances with unknown etiology [OR=3.83, 95% CI=(1.47-9.94), P=0.006] and menstrual disturbances after the first dose [OR=201.96, 95% CI= (40.99-994.90), P<0.001] were predictors of menstrual disturbances. After the third dose, a history of menstrual disturbances with unknown etiology [OR=3.09, 95% CI= (1.00-9.52), P=0.048], menstrual disturbances after the first [OR=9.82, 95% CI=(1.38-69.69), P=0.022] and second [OR=7.83, 95% CI=(1.46-41.92), P=0.016] doses could predict menstrual disturbances.
We detected that many women experienced various menstrual disturbances after vaccination against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Furthermore, a history of menstrual abnormalities (before COVID-19 vaccination and following the previous doses of these vaccines) was associated with developing menstrual disturbances.
接种新冠病毒疫苗后,一些女性出现月经周期紊乱。本研究旨在调查育龄期女性接种新冠病毒疫苗后的月经周期紊乱情况。
本横断面研究于2021年10月至2022年10月在伊玛目侯赛因医院(伊朗德黑兰)的疫苗接种中心对407名接种疫苗的女性进行。根据一份研究制定的检查表对她们进行访谈,该检查表包括关于参与者基线特征和月经周期特征的两个问题领域,以探讨接种新冠病毒疫苗后的月经特征。
与第二剂(27.9%)和第一剂(17.7%)相比,第三剂接种后月经紊乱的患病率更高(38.3%)(P<0.001)。接种第一剂后,多囊卵巢综合征病史[PCOS,优势比(OR)=7.35,95%置信区间(CI)=(3.64-14.82),P<0.001]和病因不明的月经紊乱[OR=15.23,95%CI=(6.30-36.80),P<0.001]可预测月经紊乱。接种第二剂后,病因不明的月经紊乱病史[OR=3.83,95%CI=(1.47-9.94),P=0.006]和第一剂接种后的月经紊乱[OR=201.96,95%CI=(40.99-994.90),P<0.001]是月经紊乱的预测因素。接种第三剂后,病因不明的月经紊乱病史[OR=3.09,95%CI=(1.00-9.52),P=0.048]、第一剂[OR=9.82,95%CI=(1.38-69.69),P=0.022]和第二剂[OR=7.83,95%CI=(1.46-41.92),P=0.016]接种后的月经紊乱可预测月经紊乱。
我们发现许多女性在接种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗后经历了各种月经紊乱。此外,月经异常病史(在接种新冠病毒疫苗之前和之前几剂疫苗之后)与月经紊乱的发生有关。